A nurse is caring for a patient with anorexia nervosa who presents with bradycardia, hypotension, and hypokalemia. Which intervention should the nurse prioritize to stabilize the patient's cardiovascular status?

B) Administer intravenous fluids with potassium supplementation.

A) Initiate a high-calorie diet to promote weight gain.

B) Administer intravenous fluids with potassium supplementation.

C) Increase the dosage of fluoxetine to manage anxiety.

D) Encourage the patient to engage in light physical activity to improve circulation.

A patient with anorexia nervosa presents with significant bradycardia, hypotension, and hypokalemia. Which nursing intervention should be prioritized to address the patient's cardiovascular compromise and electrolyte imbalance?

B) Initiate intravenous fluids with electrolyte replacement cautiously to stabilize cardiovascular status.

A) Administer oral potassium supplements immediately to correct hypokalemia.

B) Initiate intravenous fluids with electrolyte replacement cautiously to stabilize cardiovascular status.

C) Encourage the patient to increase oral fluid intake to improve hydration status.

D) Provide a high-calorie meal to address the nutritional deficit and improve energy levels.

A patient with a prolonged QT interval, hypokalemia, and signs of refeeding syndrome is under your care. Which of the following interventions should the nurse prioritize to prevent life-threatening cardiac arrhythmias?

D) Implement continuous cardiac monitoring to detect arrhythmias early.

A) Administer additional potassium supplements to correct hypokalemia.

B) Increase caloric intake rapidly to resolve refeeding syndrome.

C) Adjust the patient's fluoxetine dosage to address anxiety symptoms.

D) Implement continuous cardiac monitoring to detect arrhythmias early.

A patient with persistent hypokalemia and prolonged QT interval on an ECG is being monitored. The healthcare team is also addressing the risk of refeeding syndrome due to a marginal decrease in phosphate levels. Which nursing intervention is most appropriate to prioritize at this time?

C) Initiating continuous cardiac monitoring to detect potential life-threatening arrhythmias early.

A) Administering an anti-anxiety medication to manage the patient's increased anxiety.

B) Increasing the rate of electrolyte replacement therapy to rapidly correct potassium and phosphate levels.

C) Initiating continuous cardiac monitoring to detect potential life-threatening arrhythmias early.

D) Encouraging the patient to consume high-calorie foods to prevent further nutritional decline.

A patient with a history of anorexia nervosa is being monitored in a healthcare facility. Her current treatment plan includes addressing hypokalemia, prolonged QT interval, and anxiety. Which nursing intervention should be prioritized to address the risk of cardiac arrhythmias in this patient?

B) Increase the frequency of ECG monitoring to detect any changes in cardiac rhythm.

A) Administer potassium supplements as ordered and monitor serum levels closely.

B) Increase the frequency of ECG monitoring to detect any changes in cardiac rhythm.

C) Administer a low-dose benzodiazepine to reduce anxiety-related cardiac stress.

D) Educate the patient about the importance of adhering to the refeeding plan.

A patient with a history of anorexia nervosa is showing a prolonged QT interval and persistent hypokalemia despite supplementation. Which nursing intervention is most appropriate to prioritize in managing this patient's condition?

D) Review the patient's current medications for potential interactions affecting potassium levels.

A) Increase the frequency of ECG monitoring to every two hours.

B) Collaborate with the dietitian to adjust the patient's nutritional intake.

C) Administer additional potassium supplements to correct the hypokalemia.

D) Review the patient's current medications for potential interactions affecting potassium levels.

A 68-year-old female patient is experiencing persistent hypokalemia despite aggressive potassium supplementation. Her serum creatinine is mildly elevated at 1.3 mg/dL, raising concerns about possible renal impairment. Considering these findings and her current condition, what is the most appropriate nursing intervention to address the hypokalemia?

B) Assess the patient's current medication regimen for any nephrotoxic agents.

A) Increase the frequency of potassium supplementation.

B) Assess the patient's current medication regimen for any nephrotoxic agents.

C) Encourage the patient to increase her dietary intake of potassium-rich foods.

D) Restrict the patient's fluid intake to prevent further renal impairment.

A patient with a prolonged QT interval is at risk for cardiac arrhythmias. Despite aggressive potassium supplementation, the patient's hypokalemia persists, and there is a mild elevation in serum creatinine. What is the most appropriate nursing intervention to address the patient's current condition?

B) Initiate continuous cardiac monitoring to detect potential arrhythmias.

A) Increase the frequency of potassium supplementation to every 4 hours.

B) Initiate continuous cardiac monitoring to detect potential arrhythmias.

C) Recommend discontinuing all nephrotoxic medications immediately.

D) Schedule a dietary consultation to assess potassium-rich food intake.

A patient with hypokalemia and low magnesium levels is receiving intravenous magnesium sulfate and potassium supplements. The nurse is reviewing the patient's medication list and notes the patient is also taking furosemide. Which of the following actions should the nurse anticipate to address the patient's electrolyte imbalances effectively?

C) Consult with the healthcare provider about switching to a potassium-sparing diuretic

A) Discontinue all supplements and monitor levels closely

B) Increase the dose of furosemide to promote diuresis

C) Consult with the healthcare provider about switching to a potassium-sparing diuretic

D) Continue current treatment without changes

A patient with hypokalemia and mild renal insufficiency is reporting muscle weakness and fatigue. Despite supplementation, her potassium levels remain low, and her magnesium levels are slightly decreased. Which nursing intervention is most appropriate to enhance electrolyte balance and improve her symptoms?

B) Administer intravenous magnesium sulfate as ordered to correct magnesium deficiency.

A) Increase oral potassium supplementation to correct hypokalemia.

B) Administer intravenous magnesium sulfate as ordered to correct magnesium deficiency.

C) Encourage increased fluid intake to enhance renal clearance of electrolytes.

D) Discontinue all nephrotoxic medications immediately to protect renal function.

anorexia - Nursing Case Study

Pathophysiology

• Primary mechanism: Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis leads to altered neurotransmitter function, particularly serotonin and dopamine, affecting appetite control and mood regulation.

• Secondary mechanism: Neuroendocrine changes result in increased levels of stress hormones like cortisol, further suppressing appetite and contributing to the body's energy conservation processes.

• Key complication: Prolonged malnutrition from anorexia can lead to severe electrolyte imbalances, cardiovascular complications, and multi-organ dysfunction, impacting overall patient health and recovery.

Patient Profile

Demographics:

16-year-old female, high school student

History:

• Key past medical history: Diagnosed with anorexia nervosa 6 months ago, history of anxiety

• Current medications: Fluoxetine 20 mg daily, multivitamin supplement

• Allergies: None known

Current Presentation:

• Chief complaint: Feeling faint and fatigued

• Key symptoms: Significant weight loss, amenorrhea for 3 months, dizziness, cold intolerance, thinning hair

• Vital signs: Blood pressure 88/56 mmHg, heart rate 48 bpm, respiratory rate 16 breaths per minute, temperature 36.0°C, BMI 16.5 kg/m²

Section 1

As the healthcare team conducts an initial assessment, they observe that the patient's vital signs indicate significant bradycardia and hypotension, suggesting a compromised cardiovascular status due to her anorexia nervosa. Her skin appears pale and cold to the touch, and she reports feeling dizzy upon standing, a sign of potential orthostatic hypotension. Physical examination reveals lanugo hair on her arms and back, a compensatory response to her body's attempt to retain warmth. Her electrolyte panel shows hypokalemia with a potassium level of 3.0 mmol/L, raising concerns about the risk of cardiac arrhythmias. Additionally, her serum albumin is low, indicating poor nutritional status and potential protein-energy malnutrition.

These findings prompt the healthcare team to prioritize interventions aimed at stabilizing her cardiovascular status and addressing the electrolyte imbalance. Intravenous fluids with electrolyte replacement are initiated cautiously to avoid refeeding syndrome, which could further complicate her condition. The team also considers adjusting her fluoxetine dosage, as her current low body weight may affect drug metabolism and efficacy, potentially exacerbating her anxiety and mood symptoms. A nutritionist is consulted to develop a gradual refeeding plan that emphasizes caloric density and nutrient balance to support weight restoration and improve her overall health.

The patient is closely monitored for any new complications, particularly cardiac arrhythmias or signs of refeeding syndrome, such as edema or rapid shifts in electrolytes. Her ongoing symptoms of cold intolerance and fatigue are discussed within the multidisciplinary team, emphasizing the need for a holistic approach to her treatment that includes psychological support alongside medical and nutritional interventions. As her condition stabilizes, the healthcare team plans to reassess her treatment plan, focusing on long-term strategies to manage her anorexia nervosa and prevent potential relapses.

Section 2

As the healthcare team continues to monitor the patient, they observe new diagnostic results indicating a further decline in her condition. Her latest ECG shows the development of a prolonged QT interval, a concerning finding that underscores the risk of potentially life-threatening cardiac arrhythmias. This change necessitates immediate clinical reasoning to address the underlying causes, which may include the persistent hypokalemia, as her potassium level remains at 3.0 mmol/L despite initial electrolyte replacement efforts.

Concurrently, the patient's mental status appears to be affected, as she reports experiencing increased anxiety and difficulty concentrating. This shift prompts a reevaluation of her current fluoxetine dosage and the potential interactions with her compromised nutritional state. Further laboratory tests reveal a marginal decrease in her phosphate levels, raising the suspicion of incipient refeeding syndrome. The team must balance the urgency of correcting her electrolyte imbalances with the risk of precipitating additional complications, necessitating a careful reassessment of her refeeding plan.

In response to these findings, the multidisciplinary team prioritizes enhancing her cardiac monitoring and adjusting her electrolyte supplementation regimen. The nutritionist revises her refeeding plan to incorporate more gradual caloric increases while ensuring adequate phosphate and potassium intake. The team also involves a psychiatrist to evaluate her anxiety levels and adjust her medication regimen accordingly. These steps aim to stabilize her condition, prevent the escalation of complications, and support her gradual recovery. The healthcare team remains vigilant for any further changes in her status, prepared to adapt their interventions as needed to safeguard her health and well-being.

Section 3

As the healthcare team continues to closely monitor the patient, they observe a noticeable change in her overall status, signaling both progress and new challenges. Over the next 48 hours, her vital signs show a slight improvement; her heart rate stabilizes at 68 beats per minute, and blood pressure is maintained at 110/70 mmHg. However, her QT interval on the ECG remains prolonged, hovering around 470 ms, prompting continued concern over the risk of cardiac arrhythmias. The team decides to increase the frequency of her cardiac monitoring to every four hours, ensuring any sudden changes are detected promptly.

The intervention to adjust her refeeding plan shows promising results, as her phosphate levels have started to rise, now measuring 0.85 mmol/L, indicating a positive response to the revised nutritional strategy. Nonetheless, her potassium level remains stubbornly low at 3.2 mmol/L despite ongoing supplementation. This persistent hypokalemia requires further clinical reasoning to explore underlying causes such as potential renal losses or inadequate absorption, warranting additional kidney function tests and a review of her current medication interactions.

Simultaneously, the psychiatrist's evaluation reveals that the patient's anxiety is not solely attributable to her anorexic state but may also be exacerbated by her physiological instability and the side effects of fluoxetine in the context of her nutritional deficiencies. Her fluoxetine dosage is cautiously reduced, and a low-dose benzodiazepine is introduced temporarily to manage acute anxiety symptoms. The interdisciplinary team remains proactive, ready to reevaluate and adapt their strategies as the patient's condition continues to evolve, ensuring a comprehensive approach to her complex needs.

Section 4

Over the subsequent 24 hours, the patient's condition presents a mixed picture of progress and emerging complications. Her vital signs remain stable, with a heart rate of 70 beats per minute and blood pressure steady at 112/72 mmHg. However, the repeat ECG shows no significant change in the prolonged QT interval, maintaining a level of concern for potential cardiac arrhythmias. The continued risk of arrhythmias necessitates a vigilant approach, with the team considering the introduction of magnesium supplementation to address any concurrent electrolyte imbalances that might contribute to her cardiac instability.

New laboratory results highlight an unexpected development. While her phosphate levels have improved to 1.0 mmol/L, suggesting a positive response to nutritional interventions, her potassium levels have not shown the anticipated increase despite aggressive supplementation. Further investigation reveals a mild elevation in serum creatinine at 1.3 mg/dL, raising concerns about possible renal impairment contributing to her persistent hypokalemia. This finding prompts the team to initiate a comprehensive renal function assessment, including glomerular filtration rate (GFR) calculations and a review of her medication regimen for any nephrotoxic agents.

As the interdisciplinary team discusses these findings, they also reassess the patient's psychological and pharmacological management. The introduction of a low-dose benzodiazepine appears to have effectively reduced her acute anxiety symptoms, allowing for better engagement in therapy sessions. However, the team remains cautious, aware of the potential for dependency and the need for a careful tapering plan. As they continue to monitor her progress, the team prepares to address any new complications that may arise, ensuring a balanced approach that considers both her physical and mental health needs. The focus remains on gradual, sustainable improvement, with plans to further adjust her nutritional and pharmacological strategies as her condition evolves.

Section 5

The following day, the patient's condition reflects both her resilience and the complexity of her case. Her vital signs remain stable, yet a subtle change in her clinical picture prompts further investigation. Despite her stable heart rate and blood pressure, she reports mild muscle weakness and fatigue, symptoms that warrant an immediate review of her electrolyte status. The latest laboratory tests reveal a persistent hypokalemia with potassium levels still hovering at 3.0 mmol/L, despite ongoing supplementation. Additionally, her magnesium levels are slightly low at 0.7 mmol/L, which may contribute to both her muscle symptoms and the prolonged QT interval observed on the ECG.

In light of these findings, the healthcare team deliberates on a multifaceted approach to address these complications. They decide to enhance her electrolyte replenishment strategy by incorporating intravenous magnesium sulfate, aiming to stabilize her cardiac rhythm and muscle function. Concurrently, the team evaluates her renal function in detail, with a calculated GFR of 60 mL/min/1.73 m² indicating mild renal insufficiency. This prompts a careful review of her medication regimen to identify any potential nephrotoxic agents that might be exacerbating her renal function decline and contributing to her electrolyte imbalances.

The interdisciplinary team also revisits her nutritional plan, considering the potential need for adjustments to prevent refeeding syndrome while ensuring adequate electrolyte replenishment. They emphasize the importance of a balanced intake of nutrients, tailored to her specific needs, while maintaining close monitoring of her renal status and electrolyte levels. With a continued focus on her psychological well-being, the team plans to taper her benzodiazepine dosage gradually, aiming to maintain her anxiety control without risking dependency. As they implement these interventions, they remain vigilant for any additional complications, committed to steering her towards a path of recovery that harmonizes her physical and mental health needs.